David McIntosh Shares: Egypt Achieves Self-Sufficiency in Plasma-Derived Medicines Thanks to Grifols
David McIntosh, Founder and Chair of United Plasma Action, posted on LinkedIn:
“Excellent News for Egyptian Patients AND a guiding light for other nations!!
I feel sure that fellow LinkedIners with a keen interest in blood, plasma and derived life-saving medicines will have found this news as exciting as Egyptian patients did:
Read the paper here.
While the fully appropriate treatment of all patients and currently undiagnosed sufferers, across all Low and Middle Income Countries, is still a long way off, progress in Egypt must surely give hope to millions way beyond that country’s borders.
The speed of progress has been immensely impressive, immediately starting to save lives after years of unsuccessful struggling against chronic national shortages of vital plasma-derived medicines.
The key ingredients?? –
a) The successful implementation of a positive public/private partnership
and
b) The introduction of plasmapheresis collection using the time-honoured method of Voluntary Reasonably Compensated Donation (VRCD)
Thus Egypt joins Germany, Austria, Hungary and Czechia in successfully adopting the American approach to plasma collection that has served those countries so well for so many years.
A hearty cheer for patient-centred, caring, common sense!!!
Hopefully, the backwoodsmen in Europe will finally sit up and take notice. Those who still advocate for uncompensated plasma donation and allow themselves to stay reliant on US imports to treat their patients properly must surely wake up to reality some time soon ….”
Read more from David McIntosh on Hemostasis Today.
-
Nov 12, 2026, 14:35Mokhtar Tazik: Connecting Clinical Demand with Plasma Collection and Fractionation Capacity
-
Nov 12, 2026, 14:25Kim Phelan: Celebrating Dr. Marilyn Manco-Johnson as a Recipient of the 2026 Eternal Spirit Award
-
Nov 12, 2026, 14:20Shailesh Kucha: Ensuring Transfusion Safety Through Biochemical Assessment of Stored Red Cells
-
Nov 12, 2026, 14:20Akshat Jain: Wonderful Time Presenting at the ATHN 2026
-
Nov 12, 2026, 14:08Elisa Gabinaud: The Evolving Science of Megakaryocyte Development
-
Nov 12, 2026, 13:57Seyed Mohammad Sadegh Pezeshki: When Microcytosis Reveals a Complex Hemoglobinopathy
-
Nov 12, 2026, 13:45Danny Hsu: THANZ Highlights Antiphospholipid Syndrome in Upcoming Educational Webinar
-
Nov 12, 2026, 13:04Wuhan Thrombosis Congress 2026 – Bringing Global Experts Together – ISTH
-
Nov 12, 2026, 13:00Abdul Mannan: Factor IX Prophylaxis – Can Breakthrough Bleeding Still Occur?